Endo Settles New York Opioid Trial For $50M Before Judge’s Sanctions Ruling
Drug manufacturer Endo International PLC and related subsidiaries on Sept. 9 announced that they have settled an ongoing opioid trial in New York state court for $50 million, the agreement coming...To view the full article, register now.
Already a subscriber? Click here to view full article